Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 356

1.

Effect of Yokukansan on Nitric Oxide Production and Hydroxyl Radical Metabolism During Cerebral Ischemia and Reperfusion in Mice.

Kitabayashi C, Ito Y, Kawasaki H, Tanaka A, Nishioka R, Yamazato M, Ishizawa K, Nagai T, Hirayama M, Takahashi K, Yamamoto T, Araki N.

J Stroke Cerebrovasc Dis. 2019 Jan 14. pii: S1052-3057(18)30750-X. doi: 10.1016/j.jstrokecerebrovasdis.2018.12.047. [Epub ahead of print]

PMID:
30655039
2.

Tooth Loss-associated Cognitive Impairment in the Elderly: A Community-based Study in Japan.

Kato H, Takahashi Y, Iseki C, Igari R, Sato H, Sato H, Koyama S, Tobita M, Kawanami T, Iino M, Ishizawa K, Kato T.

Intern Med. 2019 Jan 10. doi: 10.2169/internalmedicine.1896-18. [Epub ahead of print]

3.

Electrolyte transport in the renal collecting duct and its regulation by the renin-angiotensin-aldosterone system.

Yamazaki O, Ishizawa K, Hirohama D, Fujita T, Shibata S.

Clin Sci (Lond). 2019 Jan 8;133(1):75-82. doi: 10.1042/CS20180194. Print 2019 Jan 15. Review.

PMID:
30622159
4.

Cognitive impairment, brain ischemia and shorter telomeres are predictors of mortality in the Japanese elderly: A 13-year prospective community-based study.

Igari R, Davy P, Sato H, Takahashi Y, Iseki C, Kato H, Sato H, Koyama S, Ishizawa K, Allsopp R, Kato T.

J Neurol Sci. 2018 Dec 31;397:129-134. doi: 10.1016/j.jns.2018.12.038. [Epub ahead of print]

PMID:
30616055
5.

Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR-ABL inhibitor use by using an adverse drug event reporting database.

Okada N, Niimura T, Zamami Y, Hamano H, Ishida S, Goda M, Takechi K, Chuma M, Imanishi M, Ishizawa K.

Cancer Med. 2018 Dec 18. doi: 10.1002/cam4.1920. [Epub ahead of print]

6.

Relationship between the administration of nicardipine hydrochloride and the development of delirium in patients on mechanical ventilation.

Zamami Y, Kouno Y, Niimura T, Chuma M, Imai T, Mitsui M, Koyama T, Kayano M, Okada N, Hamano H, Goda M, Imanishi M, Takechi K, Horinouchi Y, Kondo Y, Yanagawa H, Kitamura Y, Sendo T, Ujike Y, Ishizawa K.

Pharmazie. 2018 Dec 1;73(12):740-743. doi: 10.1691/ph.2018.8711.

PMID:
30522561
7.

Association Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective Study.

Okada N, Kawazoe H, Takechi K, Matsudate Y, Utsunomiya R, Zamami Y, Goda M, Imanishi M, Chuma M, Hidaka N, Sayama K, Kubo Y, Tanaka A, Ishizawa K.

Clin Ther. 2019 Jan;41(1):59-67. doi: 10.1016/j.clinthera.2018.11.004. Epub 2018 Dec 7.

PMID:
30528047
8.

Epstein-Barr virus-associated hemophagocytic syndrome in a patient with ulcerative colitis during treatment with azathioprine: A case report and review of literature.

Miyaguchi K, Yamaoka M, Tsuzuki Y, Ashitani K, Ohgo H, Miyagawa Y, Ishizawa K, Kayano H, Nakamoto H, Imaeda H.

World J Clin Cases. 2018 Nov 26;6(14):776-780. doi: 10.12998/wjcc.v6.i14.776.

9.

Fewer teeth are a risk factor for being underweight in community-dwelling Japanese aged 40 years and older: The Yamagata (Takahata) Study.

Ishikawa S, Konta T, Susa S, Ishizawa K, Togashi H, Ueno Y, Kubota I, Yamashita H, Kayama T, Iino M.

Int J Dent Hyg. 2018 Nov 15. doi: 10.1111/idh.12374. [Epub ahead of print]

PMID:
30431235
10.

Age-related variations in corneal geometry and their association with astigmatism: The Yamagata Study (Funagata).

Namba H, Sugano A, Nishi K, Murakami T, Nishitsuka K, Konta T, Ishizawa K, Kayama T, Yamashita H.

Medicine (Baltimore). 2018 Oct;97(43):e12894. doi: 10.1097/MD.0000000000012894.

11.

Xanthine Oxidase Inhibition by Febuxostat in Macrophages Suppresses Angiotensin II-induced Aortic Fibrosis.

Kondo M, Imanishi M, Fukushima K, Ikuto R, Murai Y, Horinouchi Y, Izawa-Ishizawa Y, Goda M, Zamami Y, Takechi K, Chuma M, Ikeda Y, Fujino H, Tsuchiya K, Ishizawa K.

Am J Hypertens. 2018 Oct 23. doi: 10.1093/ajh/hpy157. [Epub ahead of print]

PMID:
30351343
12.

Expression of TRPM8 in human reactive lymphoid tissues and mature B-cell neoplasms.

Hirai A, Aung NY, Ohe R, Nishida A, Kato T, Meng H, Ishizawa K, Fujii J, Yamakawa M.

Oncol Lett. 2018 Nov;16(5):5930-5938. doi: 10.3892/ol.2018.9386. Epub 2018 Sep 3.

13.

Development of a novel aortic dissection mouse model and evaluation of drug efficacy using in-vivo assays and database analyses.

Izawa-Ishizawa Y, Imanishi M, Zamami Y, Toya H, Nagao T, Morishita M, Tsuneyama K, Horinouchi Y, Kihira Y, Takechi K, Ikeda Y, Tsuchiya K, Yoshizumi M, Tamaki T, Ishizawa K.

J Hypertens. 2019 Jan;37(1):73-83. doi: 10.1097/HJH.0000000000001898.

PMID:
30303488
14.

The association between urinary sodium excretion and blood pressure in a community-based population: the Yamagata (Takahata) study.

Watanabe S, Konta T, Ichikawa K, Watanabe M, Ishizawa K, Ueno Y, Yamashita H, Kayama T, Kubota I.

Clin Exp Nephrol. 2018 Oct 6. doi: 10.1007/s10157-018-1654-3. [Epub ahead of print]

PMID:
30293215
15.

S100A10 upregulation associates with poor prognosis in lung squamous cell carcinoma.

Sato K, Saiki Y, Arai K, Ishizawa K, Fukushige S, Aoki K, Abe J, Takahashi S, Sato I, Sakurada A, Okada Y, Horii A.

Biochem Biophys Res Commun. 2018 Oct 28;505(2):466-470. doi: 10.1016/j.bbrc.2018.09.118. Epub 2018 Sep 27.

PMID:
30268496
16.

Nitrosonifedipine, a Photodegradation Product of Nifedipine, Suppresses Pharmacologically Induced Aortic Aneurysm Formation.

Imanishi M, Izawa-Ishizawa Y, Sakurada T, Kohara Y, Horinouchi Y, Sairyo E, Zamami Y, Takechi K, Chuma M, Fukushima K, Ikeda Y, Fujino H, Yoshizumi M, Tsuchiya K, Tamaki T, Ishizawa K.

Pharmacology. 2018;102(5-6):287-299. doi: 10.1159/000492577. Epub 2018 Sep 25.

PMID:
30253416
17.

An autopsy report of three kindred in a Gerstmann-Sträussler-Scheinker disease P105L family with a special reference to prion protein, tau, and beta-amyloid.

Ishizawa K, Mitsufuji T, Shioda K, Kobayashi A, Komori T, Nakazato Y, Kitamoto T, Araki N, Yamamoto T, Sasaki A.

Brain Behav. 2018 Oct;8(10):e01117. doi: 10.1002/brb3.1117. Epub 2018 Sep 21.

18.

Development and pharmacist-mediated use of tools for monitoring atypical antipsychotic-induced side effects related to blood glucose levels.

Ishida S, Takechi K, Bando H, Imanishi M, Zamami Y, Chuma M, Yanagawa H, Kirino Y, Nakamura T, Teraoka K, Ishizawa K.

Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1379-1384. doi: 10.1002/pds.4656. Epub 2018 Sep 17.

PMID:
30221424
19.

Risk factors for tooth loss in community-dwelling Japanese aged 40 years and older: the Yamagata (Takahata) study.

Ishikawa S, Konta T, Susa S, Kitabatake K, Ishizawa K, Togashi H, Tsuya A, Ueno Y, Kubota I, Yamashita H, Kayama T, Iino M.

Clin Oral Investig. 2018 Aug 30. doi: 10.1007/s00784-018-2604-x. [Epub ahead of print]

PMID:
30167794
20.

Irinotecan-induced neutropenia is reduced by oral alkalization drugs: analysis using retrospective chart reviews and the spontaneous reporting database.

Hamano H, Mitsui M, Zamami Y, Takechi K, Nimura T, Okada N, Fukushima K, Imanishi M, Chuma M, Horinouchi Y, Izawa-Ishizawa Y, Kirino Y, Nakamura T, Teraoka K, Ikeda Y, Fujino H, Yanagawa H, Tamaki T, Ishizawa K.

Support Care Cancer. 2018 Jul 31. doi: 10.1007/s00520-018-4367-y. [Epub ahead of print]

PMID:
30062585
21.

Safety and efficacy of high-dose ranimustine (MCNU) containing regimen followed by autologous stem cell transplantation for diffuse large B-cell lymphoma.

Kameoka Y, Akagi T, Murai K, Noji H, Kato Y, Sasaki O, Ito S, Ishizawa K, Ishida Y, Ichinohasama R, Harigae H, Takahashi N.

Int J Hematol. 2018 Nov;108(5):510-515. doi: 10.1007/s12185-018-2508-1. Epub 2018 Jul 24.

PMID:
30043334
22.

Renoprotective effects of a factor Xa inhibitor: fusion of basic research and a database analysis.

Horinouchi Y, Ikeda Y, Fukushima K, Imanishi M, Hamano H, Izawa-Ishizawa Y, Zamami Y, Takechi K, Miyamoto L, Fujino H, Ishizawa K, Tsuchiya K, Tamaki T.

Sci Rep. 2018 Jul 18;8(1):10858. doi: 10.1038/s41598-018-29008-2.

23.

ULK1 Phosphorylates and Regulates Mineralocorticoid Receptor.

Shibata S, Ishizawa K, Wang Q, Xu N, Fujita T, Uchida S, Lifton RP.

Cell Rep. 2018 Jul 17;24(3):569-576. doi: 10.1016/j.celrep.2018.06.072.

24.

A Novel SDHB IVS2-2A>C Mutation Is Responsible for Hereditary Pheochromocytoma/Paraganglioma Syndrome.

Yamanaka M, Shiga K, Fujiwara S, Mizuguchi Y, Yasuda S, Ishizawa K, Saiki Y, Higashi K, Ogawa T, Kimura N, Horii A.

Tohoku J Exp Med. 2018 Jun;245(2):99-105. doi: 10.1620/tjem.245.99.

25.

Phase III study of watchful waiting vs. rituximab as first-line treatment in advanced stage follicular lymphoma with low tumour burden (JCOG1411, FLORA study).

Miyamoto K, Fukuhara N, Maruyama D, Shibata T, Nakamura K, Ishizawa K, Tsukasaki K, Nagai H; Lymphoma Study Group of the Japan Clinical Oncology Group.

Jpn J Clin Oncol. 2018 Aug 1;48(8):777-780. doi: 10.1093/jjco/hyy085.

PMID:
29901705
26.

The Association between Glomerular Filtration Rate Estimated Using Different Equations and Mortality in the Japanese Community-Based Population: The Yamagata (Takahata) Study.

Kabasawa A, Konta T, Suzuki N, Kamei K, Watanabe S, Araumi A, Matsuki E, Kon S, Oyama M, Ichikawa K, Ishizawa K, Ueno Y, Yamashita H, Kayama T, Kubota I.

Dis Markers. 2018 Feb 19;2018:9191832. doi: 10.1155/2018/9191832. eCollection 2018.

27.

Administration of Kampo medicine through a tube at an advanced critical care center.

Niimura T, Zamami Y, Imai T, Ito T, Sagara H, Hiroyuki H, Esumi S, Takechi K, Imanishi M, Koyama T, Amano M, Kurata N, Kitamura Y, Nakura H, Sendo T, Ishizawa K.

J Med Invest. 2018;65(1.2):32-36. doi: 10.2152/jmi.65.32.

28.

Successful Cord Blood Stem Cell Transplantation for Primary Cutaneous CD8-positive Aggressive Epidermotropic Cytotoxic T-cell Lymphoma Complicated with Cerebral Infiltration.

Ichikawa S, Fukuhara N, Hatta S, Himuro M, Katsushima H, Nasu K, Ono K, Inokura K, Kobayashi M, Onishi Y, Fujii H, Ishizawa K, Ichinohasama R, Harigae H.

Intern Med. 2018 Jul 15;57(14):2051-2055. doi: 10.2169/internalmedicine.0568-17. Epub 2018 Mar 9.

29.

Evaluation of the Benefits of De-Escalation for Patients with Sepsis in the Emergency Intensive Care Unit.

Niimura T, Zamami Y, Imai T, Nagao K, Kayano M, Sagara H, Goda M, Okada N, Chuma M, Takechi K, Imanishi M, Koyama T, Koga T, Nakura H, Sendo T, Ishizawa K.

J Pharm Pharm Sci. 2018;21(1):54-59. doi: 10.29173/jpps29737.

30.

Effects of Memantine on Nitric Oxide Production and Hydroxyl Radical Metabolism during Cerebral Ischemia and Reperfusion in Mice.

Tanaka A, Ito Y, Kawasaki H, Kitabayashi C, Nishioka R, Yamazato M, Ishizawa K, Nagai T, Hirayama M, Takahashi K, Yamamoto T, Araki N.

J Stroke Cerebrovasc Dis. 2018 Jun;27(6):1609-1615. doi: 10.1016/j.jstrokecerebrovasdis.2018.01.014.

PMID:
29426680
31.

Detection of Minimal Bone Marrow involvement of Blastic Plasmacytoid Dendritic Cell Neoplastic Cells - CD303 immunostaining as a diagnostic tool.

Ohe R, Aung NY, Shiono Y, Utsunomiya A, Kabasawa T, Tamazawa N, Tamura Y, Kato T, Yamada A, Hasegawa S, Aizawa K, Inokura K, Ito S, Toubai T, Kato Y, Tsunoda T, Onami K, Suzuki T, Ishizawa K, Yamakawa M.

J Clin Exp Hematop. 2018 Mar 16;58(1):1-9. doi: 10.3960/jslrt.17030. Epub 2018 Feb 8.

32.

Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study.

Harada Y, Nagata Y, Kihara R, Ishikawa Y, Asou N, Ohtake S, Miyawaki S, Sakura T, Ozawa Y, Usui N, Kanamori H, Ito Y, Imai K, Suehiro Y, Kobayashi S, Kitamura K, Sakaida E, Onizuka M, Takeshita A, Ishida F, Suzushima H, Ishizawa K, Naoe T, Matsumura I, Miyazaki Y, Ogawa S, Kiyoi H; Japan Adult Leukemia Study Group JALSG.

Leuk Res. 2018 Mar;66:20-27. doi: 10.1016/j.leukres.2018.01.008. Epub 2018 Jan 17.

PMID:
29360622
33.

Potential Usefulness of Early Potassium Supplementation for Preventing Severe Hypokalemia Induced by Liposomal Amphotericin B in Hematologic Patients: A Retrospective Study.

Okada N, Azuma M, Imanishi M, Zamami Y, Kirino Y, Nakamura T, Teraoka K, Abe M, Ishizawa K.

Clin Ther. 2018 Feb;40(2):252-260. doi: 10.1016/j.clinthera.2017.12.006. Epub 2018 Jan 2.

PMID:
29305017
34.

Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest.

Niimura T, Zamami Y, Koyama T, Izawa-Ishizawa Y, Miyake M, Koga T, Harada K, Ohshima A, Imai T, Kondo Y, Imanishi M, Takechi K, Fukushima K, Horinouchi Y, Ikeda Y, Fujino H, Tsuchiya K, Tamaki T, Hinotsu S, Kano MR, Ishizawa K.

Sci Rep. 2017 Dec 20;7(1):17919. doi: 10.1038/s41598-017-17686-3.

35.

Pharmacy Students' Knowledge and Attitude toward Registration Trials and Clinical Research: A Survey in a Japanese University Hospital.

Ise N, Takechi K, Miyamoto T, Ishizawa K, Yanagawa H.

Pharmacy (Basel). 2017 Dec 11;5(4). pii: E67. doi: 10.3390/pharmacy5040067.

36.

[Lenalidomide and low-dose dexamethasone therapy for Japanese patients with newly diagnosed multiple myeloma: updated results of the MM-025 study].

Ando K, Chou T, Suzuki K, Shinagawa A, Uchida T, Taniwaki M, Hirata H, Ishizawa K, Matsue K, Okamoto S, Otsuka M, Matsumoto M, Iida S, Matsumura I, Ikeda T, Takezako N, Ogaki Y, Midorikawa S, Houck V, Ervin-Haynes A, Terui Y.

Rinsho Ketsueki. 2017;58(11):2219-2226. doi: 10.11406/rinketsu.58.2219. Japanese.

PMID:
29212972
37.

[Drug Repositioning Research Utilizing a Large-scale Medical Claims Database to Improve Survival Rates after Cardiopulmonary Arrest].

Zamami Y, Niimura T, Takechi K, Imanishi M, Koyama T, Ishizawa K.

Yakugaku Zasshi. 2017;137(12):1439-1442. doi: 10.1248/yakushi.17-00139-3. Review. Japanese.

38.

[Change Emergency Intensive Care!!Create and Disseminate Evidence That Contributes to Improving the Treatment of Critically Ill Patients].

Ishizawa K, Irie T.

Yakugaku Zasshi. 2017;137(12):1425. doi: 10.1248/yakushi.17-00139-F. Japanese. No abstract available.

39.

Progressive Pseudolithiasis Associated with the Intravenous Administration of Ceftriaxone in Patients with Central Nervous System Infections.

Tsukagoshi S, Ishizawa K, Hirayanagi K, Nagamine S, Makioka K, Fujita Y, Ikeda Y.

Intern Med. 2017 Dec 1;56(23):3189-3192. doi: 10.2169/internalmedicine.8826-17. Epub 2017 Oct 11.

40.

The uremic toxin indoxyl sulfate interferes with iron metabolism by regulating hepcidin in chronic kidney disease.

Hamano H, Ikeda Y, Watanabe H, Horinouchi Y, Izawa-Ishizawa Y, Imanishi M, Zamami Y, Takechi K, Miyamoto L, Ishizawa K, Tsuchiya K, Tamaki T.

Nephrol Dial Transplant. 2017 Aug 23. doi: 10.1093/ndt/gfx252. [Epub ahead of print]

PMID:
28992067
41.

Meta-analysis of the efficacies of amiodarone and nifekalant in shock-resistant ventricular fibrillation and pulseless ventricular tachycardia.

Sato S, Zamami Y, Imai T, Tanaka S, Koyama T, Niimura T, Chuma M, Koga T, Takechi K, Kurata Y, Kondo Y, Izawa-Ishizawa Y, Sendo T, Nakura H, Ishizawa K.

Sci Rep. 2017 Oct 4;7(1):12683. doi: 10.1038/s41598-017-13073-0.

42.

Psychiatric Patients with Antipsychotic Drug-Induced Hyperprolactinemia and Menstruation Disorders.

Takechi K, Yoshioka Y, Kawazoe H, Tanaka M, Takatori S, Kobayashi M, Matsuoka I, Yanagawa H, Zamami Y, Imanishi M, Ishizawa K, Tanaka A, Araki H.

Biol Pharm Bull. 2017;40(10):1775-1778. doi: 10.1248/bpb.b17-00053.

43.

Pharmacological approach for drug repositioning against cardiorenal diseases.

Zamami Y, Imanishi M, Takechi K, Ishizawa K.

J Med Invest. 2017;64(3.4):197-201. doi: 10.2152/jmi.64.197. Review.

44.

Epidemiological and clinical features of adult T-cell leukemia-lymphoma in Japan, 2010-2011: A nationwide survey.

Nosaka K, Iwanaga M, Imaizumi Y, Ishitsuka K, Ishizawa K, Ishida Y, Amano M, Ishida T, Uike N, Utsunomiya A, Ohshima K, Kawai K, Tanaka J, Tokura Y, Tobinai K, Watanabe T, Uchimaru K, Tsukasaki K.

Cancer Sci. 2017 Dec;108(12):2478-2486. doi: 10.1111/cas.13398. Epub 2017 Oct 8.

45.

Dietary iron restriction alleviates renal tubulointerstitial injury induced by protein overload in mice.

Ikeda Y, Horinouchi Y, Hamano H, Hirayama T, Kishi S, Izawa-Ishizawa Y, Imanishi M, Zamami Y, Takechi K, Miyamoto L, Ishizawa K, Aihara KI, Nagasawa H, Tsuchiya K, Tamaki T.

Sci Rep. 2017 Sep 6;7(1):10621. doi: 10.1038/s41598-017-11089-0.

46.

Boron-Catalyzed Carboxylic Acid-Selective Aldol Reaction with Trifluoromethyl Ketones.

Ishizawa K, Nagai H, Shimizu Y, Kanai M.

Chem Pharm Bull (Tokyo). 2018 Mar 1;66(3):231-234. doi: 10.1248/cpb.c17-00545. Epub 2017 Aug 19.

47.

Ectopic cerebellar tissue in the occipital bone: a case report.

Kawashima M, Kobayashi M, Ishizawa K, Fujimaki T.

J Med Case Rep. 2017 Aug 21;11(1):231. doi: 10.1186/s13256-017-1394-0.

48.

Does double-hit follicular lymphoma with translocations of MYC and BCL2 change the definition of transformation?

Katsushima H, Fukuhara N, Konosu-Fukaya S, Himuro M, Kitawaki Y, Ichikawa S, Ishizawa K, Sasano H, Harigae H, Ichinohasama R.

Leuk Lymphoma. 2018 Mar;59(3):758-762. doi: 10.1080/10428194.2017.1357172. Epub 2017 Aug 3. No abstract available.

PMID:
28771060
49.

Kamishoyosan and Shakuyakukanzoto promote recovery from paclitaxel-induced neurite retraction in PC12 cells.

Konaka K, Moriyama K, Sakurada T, Okada N, Imanishi M, Zamami Y, Kawazoe K, Fushitani S, Ishizawa K.

J Pharm Health Care Sci. 2017 Jul 21;3:20. doi: 10.1186/s40780-017-0090-y. eCollection 2017.

50.

Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy.

Inoue-Yamauchi A, Jeng PS, Kim K, Chen HC, Han S, Ganesan YT, Ishizawa K, Jebiwott S, Dong Y, Pietanza MC, Hellmann MD, Kris MG, Hsieh JJ, Cheng EH.

Nat Commun. 2017 Jul 17;8:16078. doi: 10.1038/ncomms16078.

Supplemental Content

Loading ...
Support Center